AI Article Synopsis
- After percutaneous coronary intervention (PCI) for acute STEMI, inflammation can increase the risk of no-reflow due to microvascular obstruction, but the relationship with inflammatory factors remains debated.
- A meta-analysis was performed by reviewing studies from various databases, focusing on case-control and cohort studies, while excluding irrelevant publications and data issues.
- Findings revealed that elevated levels of high-sensitivity C-reactive protein, platelet/lymphocyte ratio, leukocyte count, neutrophil count, and increased red blood cell volume width are significantly linked to the risk of no-reflow, offering useful information for clinicians.
Article Abstract
Background: After percutaneous coronary intervention (PCI), patients with acute ST-segment elevation myocardial infarction (STEMI) could have an inflammatory response, which may lead to the risk of no-reflow due to microvascular obstruction. However, the association between changes in the levels of inflammatory response-related factors and no-reflow after PCI in patients with acute STEMI is still controversial.
Methods: In this study, a meta-analysis was conducted. Studies from the database established before April 2024 were retrieved in PubMed, Web of Science, and EMBASE. Case-control or cohort studies were included. Repetitive publications, studies without full access and successful data extraction, fragmentary information, animal experiments, summary, and systematic reviews were excluded, and Review Manager 5.3 software was used to process the data.
Results: The meta-analysis showed that elevated levels of high-sensitivity C-reactive protein (Hs-CRP) ( = 22.87, < 0.001), platelet/lymphocyte ratio (PLR) ( = 19.17, < 0.001), leukocyte ( = 9.98, < 0.001), and neutrophil count ( = 5.75, < 0.001) were significantly related with the risk of no-reflow. In addition, the increase of red blood cell volume width (RDW) was also a risk factor for no-reflow.
Conclusion: Refined results of Hs-CRP, PLR, RDW, leukocytes, and neutrophil can provide clinicians with effective tools to reduce the risk of no-reflow in patients with acute STEMI after PCI.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558390 | PMC |
| http://dx.doi.org/10.62347/SUQT4991 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Post-acute sequelae of SARS-CoV-2 and kidney events in U.S. active component service members, March 1, 2020-September 30, 2022.
MSMR
December 2024
Epidemiology and Analysis Branch, Armed Forces Health Surveillance Division, Defense Health Agency, U.S. Department of Defense, Silver Spring, MD.
Early evidence suggests that COVID-19 is linked to kidney-related events in older and hospitalized patients. This link has not, however, been explored among a younger, healthy population such as U.S.
View Article and Find Full Text PDFEvaluating general practitioners' focused lung ultrasound competence and findings in patients with suspected community-acquired pneumonia in general practice.
Scand J Prim Health Care
December 2024
Center for General Practice at Aalborg University, Aalborg, Denmark.
Objectives: To evaluate general practitioners' (GPs') ability to perform focused lung ultrasound (FLUS) following a training program and assess FLUS feasibility in general practice. Also, to describe FLUS findings and evaluate GPs' ability to interpret these in adults with acute lower respiratory tract infection (LRTI) when pneumonia is suspected and assess GPs' perception of FLUS impact.
Methods: Nine GPs, using point-of-care ultrasound, completed a FLUS training program.
B-Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Mimicking Fibrosing Mediastinitis: A Case Report and Diagnostic Insight.
Am J Case Rep
December 2024
Division of Respirology, Rheumatology, Infectious Diseases, and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Kiyotake, Miyazaki, Japan.
BACKGROUND Fibrosing mediastinitis (FM) is a rare, fibroproliferative disorder within the mediastinum. It is extremely rare for hematologic malignancies to develop as FM. CASE REPORT A 32-year-old Japanese man with a 1-month history of headache and 2-week history of facial swelling underwent chest computed tomography (CT); a diffuse mass-like lesion was revealed in the anterior mediastinum with severe stenosis of vital mediastinal organs.
View Article and Find Full Text PDFDexmedetomidine Mitigates Acute Lung Injury by Enhancing M2 Macrophage Polarization and Inhibiting RAGE/Caspase-11-Mediated Pyroptosis.
Front Biosci (Landmark Ed)
December 2024
Department of Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, 400016 Chongqing, China.
Background: Acute lung injury (ALI) significantly impacts the survival rates in intensive care units (ICU). Releasing a lot of pro-inflammatory mediators during the progression of the disease is a core feature of ALI, which may lead to uncontrolled inflammation and further damages the tissues and organs of patients. This study explores the potential therapeutic mechanisms of Dexmedetomidine (Dex) in ALI.
View Article and Find Full Text PDFLeft Atrial Strain in Omicron-Type COVID-19 Patients.
CJC Open
December 2024
Department of Cardiology, Tel Aviv Medical Center and School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Background: Information about left atrial (LA) 2-dimensional (2D) strain parameters in patients with the Omicron variant of COVID-19 is limited. The aim of this study is to evaluate LA strain (LAS) in COVID-19 patients with the Omicron variant and compare it to that of propensity-matched patients with the wild-type (WT) variant.
Methods: A total of 148 consecutive patients who were hospitalized with Omicron COVID-19 underwent an echocardiographic evaluation within the first day after hospital admission and were compared to propensity-matched patients (1:1) with the WT variant.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!